News
        
        AI Spending in Healthcare To Rise as Investments Pay Off
        
        
        
        More than 80 percent of healthcare professionals surveyed for a recent Nvidia  report credited AI use for helping increase their revenues.
That's one of the takeaways of the AI giant's first ever "State of  AI in Healthcare and Life Sciences" report, which surveyed over 600  healthcare professionals around the world, including insurers, digital healthcare  providers, pharmacy techs and more, about how they're using AI in their  organizations. 
Nvidia found that a "robust" amount (about 66 percent) of  respondents are actively using AI -- and to measurable benefits. Nearly half (45  percent) said their AI use helped increase their revenues within a single year. 
"The healthcare and life sciences industry is seeing how AI can  help increase annual revenue and reduce operational costs," Nvidia said in  a press  release about the report. "Forty-one percent of respondents indicated  that the acceleration of research and development has had a positive impact.  Thirty-six percent of respondents said AI has helped create a competitive  advantage. And 35% have said it’s helped reduce project cycles, deliver better  clinical or research insights, and enhance precision and accuracy,  respectively."
Given those returns, most of the survey pool said they plan to invest  even more on AI this year -- 78 percent, to be exact. About 33 percent expect their  AI budgets to increase by at least 10 percent. 
Nearly half (48 percent) of respondent said "identifying  additional AI use cases" is a major spending priority of, while just over  a third (34 percent) expect to focus their spending on "optimizing  workflow and production cycles." About one-quarter (26 percent) plan to  spend their AI budgets on new hires with AI expertise. 
Among the report's other findings:
  - "58% cited data analytics as the top AI  workload, with generative AI second at 54%, and large language models third at  53%."
- "59% of respondents from pharmaceutical and  biotech companies cited drug discovery and development among their top AI use  cases."
- "[I]n the payers and providers industry  segment...48% of respondents said their top AI use case was administrative  tasks and workflow optimization."
- "For the medical tools and technologies  field, 71% of respondents said their top AI use case was medical imaging and  diagnostics." 
- "[F]or digital healthcare, 54% of  respondents said their top use case was clinical decision support. 
- "54% from the pharmaceutical and biotech  fields prioritized drug discovery and development.